Derrell Porter

SVP, Head of Global Commercial, Atara Biotherapeutics, Inc.

Companies

Acumen Pharmaceuticals, Inc.Board member Jan 4, 2023 to now¹
Passage BIO, Inc.Board member May 28, 2021 to now²
Atara Biotherapeutics, Inc.SVP, Head of Global Commercial May 11, 2017 to Mar 27, 2019³

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 17, 2026Sold 13,040 shares at $2.33 of Acumen Pharmaceuticals, Inc.⁴
Jun 17, 2026Exercised options 13,040 shares at $1.07 of Acumen Pharmaceuticals, Inc.⁴
Jun 16, 2026Sold 12,800 shares at $2.33 of Acumen Pharmaceuticals, Inc.⁴
Jun 15, 2026Sold 6,460 shares at $2.35 of Acumen Pharmaceuticals, Inc.⁴
Jun 15, 2026Exercised options 6,460 shares at $1.07 of Acumen Pharmaceuticals, Inc.⁴
Jun 3, 2026Granted 35,500 shares of Acumen Pharmaceuticals, Inc.⁵
Jun 4, 2025Granted 12,800 shares of Acumen Pharmaceuticals, Inc.⁶

The numbers on this page point here. Each one links to the record it came from.